Malaysia Begins Phase 3 Trials Of China-developed COVID-19 Vaccine
Muhammad Irfan Published January 27, 2021 | 02:50 PM
Malaysia has begun a phase 3 clinical trial of a COVID-19 vaccine candidate developed by the Institute of Medical Biology of the Chinese Academy of Medical Sciences (IMBCAMS), the Health Ministry said on Wednesday
KUALA LUMPUR (APP - UrduPoint / Pakistan Point News - 27th Jan, 2021 ) :Malaysia has begun a phase 3 clinical trial of a COVID-19 vaccine candidate developed by the Institute of Medical Biology of the Chinese academy of Medical Sciences (IMBCAMS), the Health Ministry said on Wednesday.
The initiative is a collaboration between the governments of Malaysia and China to generate scientific data in the development of the vaccine candidate to evaluate its safety and efficacy against COVID-19 infection, the ministry said in a statement.
The trials will involve nine government hospitals across Malaysia and 3,000 volunteers for a period of 13 months.
In his speech during the virtual launching ceremony, Malaysian Health Minister Adham Baba said Malaysia is very pleased to work with China, through IMBCAMS in contributing to the search for scientific evidence in the development of the inactivated vaccine.
"With strong regulatory, certified researchers and experienced research sites, we are confident of producing quality scientific evidence to support the research vaccine," he said.
"This cooperation will strengthen ties between China and Malaysia. I am very confident that we will have more opportunities to work together in the near future, bringing more positive results not only for both our countries, but also for the world," Adham said.
For his part, Che Yanchun, head of the R&D Department, Chinese Institute of Medical Sciences Academy of Medical Sciences, said Malaysia has been chosen as the first country outside China to participate in this phase 3 clinical trial of the COVID-19 vaccine which would also take place in other countries.
"I sincerely hope the phase 3 clinical trial in Malaysia will be a successful one, and it will fulfill the objectives of the clinical trial, and certainly Malaysia will also get the benefits from this trial," Che said.
Related Topics
Recent Stories
Rock-solid Ruud racks up season-leading win in Barcelona
At UN, Iran says it will make Israel 'regret' reprisals
G7 hears calls for 'critical' Ukraine aid
EU seeks to leverage might to confront China, US challenge
5 Customs officials martyred as their vehicle ambushed by terrorists in D I Khan
Pak-New Zealand match called off due to rain
NHA restores traffic on roads affected by recent rains in Balochistan
China to fully support Pakistan's efforts against terrorism: Ambassador Jiang
U.S. envoy calls on Foreign Minister Ishaq Dar
Poland arrests man over suspected plan to kill Zelensky
EU wants to ease youth movement to and from UK
Police foils attempt of supply mainpuri raw material
More Stories From World
-
At G7, Blinken seeks European support for pressure on China
2 hours ago -
Thousands of Bosnian Serbs rally against UN resolution on Srebrenica
2 hours ago -
Israel assault has turned Gaza into 'humanitarian hellscape': UN
3 hours ago -
Husband of ex-Scottish leader charged over alleged embezzlement: police
3 hours ago -
Ecuador hit by power cuts of up to 13 hours amid drought
3 hours ago -
Hugs or bullets? How Mexico presidential rivals aim to curb violence
3 hours ago
-
Kenya military chopper crash kills defence chief, senior officers
4 hours ago -
Biden hails 'incredible' Kennedy family backing against RFK Jr.
4 hours ago -
Maldives court frees jailed ex-president ahead of vote
4 hours ago -
Probe into Portugal ex-PM Costa appears to collapse
4 hours ago -
Jury selection stalls in Trump criminal trial
4 hours ago -
At UN, Iran says it will make Israel 'regret' reprisals
4 hours ago